Abstract
Recent studies demonstrated that progression of chronic kidney disease (CKD) over a 1-year period is associated with a substantially increased risk of mortality. Cystatin C has emerged as a reliable marker of kidney function. In this study, we evaluated the factors associated with increase in cystatin C over a 1-year period in patients with cardiovascular disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
